Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118271) titled 'The Application of New Lymphatic Tracers Mitozantrone Hydrochloride in Improving the Efficacy and Prognosis of Patients After Radical Surgery for Differentiated Thyroid Cancer' on Feb. 3.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Tianjin First Central Hospital
Condition:
Thyroid tumor
Intervention:
The experimental group:In the experimental group, mitoxantrone hydrochloride was used as a tracer for lymph node staining during radical thyroid cancer surgery.
The control group:In the control group, carbon nanoparticles were used for lymph node staining and tracing during radical...